Cite
HARVARD Citation
Pohl, E. et al. (n.d.). 243PGermline mutation status and therapy response in patients with triple-negative breast cancer (TNBC): Results of the GeparOcto study. Annals of oncology. p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Pohl, E. et al. (n.d.). 243PGermline mutation status and therapy response in patients with triple-negative breast cancer (TNBC): Results of the GeparOcto study. Annals of oncology. p. . [Online].